Virgin Australia unsecured bondholders contesting the sale of the embattled airline to private equity firm Bain Capital have failed in their bid to access confidential transaction documents, but a judge has urged the administrators to communicate with the frustrated creditors.
Costs orders should be the exception in funded Fair Work cases, judge says
Judge grapples with ‘most complicated’ adjournment bid in Hytera, Motorola dispute
Virgin bondholders blast Deloitte disclosures to court
Opal Tower owners’ corporation opts out of class action
Judge says FWC can hear dispute over stood down Qantas, Jetstar engineers
Border closure case pushed off as expert helps Victoria with second coronavirus wave
ACCC greenlights acquisition of Bayer’s animal health business
Decade-long dispute over vehicle parking monitoring patent rolls on
The race for the COVID-19 vaccine and patents: Do we need a temporary lockdown?
It is entirely possible that the first effective SARS-CoV-2 vaccine is developed in Australia, with an Australian firm securing patent rights to the vaccine. If that occurs, it is important to remember that a patent is not an impenetrable fortress. Patent laws already contain mechanisms to enable “special access” to patented pharmaceuticals and other technologies, including (perhaps especially) in times like this, say James Neil and Richard Hoad of Clayton Utz.